11β-HSD1-IN-8
11β-HSD1-IN-8 (compound c6a) is a 11β HSD1 inhibitor with an IC50 value of 2.3 μM for human 11β HSD1. 11β-HSD1-IN-8 can be used for the research of diabetes and cognitive decline[1].
Product Specifications
CAS Number
386704-15-0
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
11β-HSD
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/11β-hsd1-in-8.html
Purity
95.0
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
COC(=O)CC(=O)C1=CN=C(C=C1)C(F)(F)F
Molecular Formula
C10H8F3NO3
Molecular Weight
247.17
Precautions
H302, H315, H319, H335
References & Citations
[1]Naredo-Gonzalez G, et al. Non-invasive in vivo assessment of 11β-hydroxysteroid dehydrogenase type 1 activity by 19F-Magnetic Resonance Spectroscopy. Sci Rep. 2022 Sep 29;12 (1) :16268.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040257-500 1x 500 µL
Cytokeratin, HMW (AE-3), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470200-100 1x 100 µL
MHC II (HLA-DQ) (SPV-L3), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 